S. Uhle

A blood-based miRNA signature with prognostic value for overall survival in advanced stage non-small cell lung cancer treated with immunotherapy

K. Rabe, R. Horos, Michael Thomas, 2022, npj Precision Oncology.

A blood-based miRNA signature predicts immunotherapy efficacy in advanced stage non-small cell lung cancer

K. Rabe, R. Horos, T. Sauka-Spengler, 2021, medRxiv.

Low-Density Granulocyte Contamination From Peripheral Blood Mononuclear Cells of Patients With Sepsis and How to Remove It – A Technical Report

M. Weigand, F. Uhle, J. Schenz, 2021, Frontiers in Immunology.